Montaya, Bb Girl .

HRN: 23-59-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
CEFTAZIDIME 1GM (VIAL)
08/30/2023
09/05/2023
IV
75mg
Q12h
Possible Septic Newborn
Waiting Final Action 
08/30/2023
AMPICILLIN 250MG (VIAL)
08/30/2023
09/05/2023
IV
125mg
Q12h
Possible Septic Newborn
Waiting Final Action 
09/04/2023
CEFTAZIDIME 1GM (VIAL)
09/04/2023
09/05/2023
IV
75 Mg
Q12
Possible Septic Newborn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: